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Dendritic cells (DC) present lipid and peptide antigens to T cells on CD1
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CD1 ͉ Mycobacterium tuberculosis ͉ MHCII ͉ immune evasion T he initiation of adaptive immunity relies on pathogen detection via pattern recognition receptors, including Toll-like receptors (TLR). The recognition of microbial components in dendritic cells (DC) via TLR signaling provides a link between microbial detection and the presentation of microbial antigens to T cells (1) . DC maturation sequentially links antigen uptake and processing with MHC Class II (MHCII) loading followed by delivery of MHCIIantigen complexes to the cell surface. Immature DCs exhibit a high endocytic rate that enables efficient antigen uptake (2) . They express low surface levels of MHCII, which instead is primarily localized to specialized late endocytic multilamellar or multivesicular lysosomes, or MHCII compartments (MIIC) (3) . Exposure to TLR ligands or inflammatory cytokines induces the efficient redistribution of MHCII to the plasma membrane where it is stably expressed and displays peptides to T cells (4) (5) (6) (7) . DCs also express the group 1 CD1 isoforms (CD1a, CD1b, and CD1c), which present microbial lipid antigens to T cells (8) . CD1b colocalizes with MHCII in the MIIC of immature DCs (9, 10) . Unlike MHCII, the trafficking of CD1b is unaffected by DC maturation, and CD1b presents antigens equally well in both immature and mature DCs (11, 12) , indicating that CD1b-restricted antigen presentation is not subject to the same strict DC maturation program as MHCII.
Many CD1-presented microbial lipids are derived from the cell wall Mycobacterium tuberculosis (Mtb) (8) . Mtb evades the microcidal capabilities of antigen-presenting cells through the modulation of host signaling pathways resulting in long-term persistence in infected hosts. These strategies include the alteration of phagosome maturation in macrophages (13) . In contrast, DCs are less able to support the growth of Mtb during the initial 48 h after phagocytosis (14, 15) , and following this time, Mtb have the ability to escape from phagolysosomes to replicate in the cytosol of DC (14) . In all of these instances, the intersection of Mtb with the MHCII antigen presentation pathway is changed. Given that DCs are required for the initiation of Mtb-specific adaptive immune responses (16) (17) (18) , these findings raise the issue of when during the course of infection DC are able to stimulate MHCII responses.
Further, because MHCII and CD1b traffic differently during DC maturation, we sought to determine whether their antigen presentation functions differently after Mtb infection of DCs, potentially leading to the discrete induction of lipid and peptide immune responses. Strikingly, we find that lipid antigen presentation by CD1b is detected within the first day after infection of DC, whereas MHCII responses are delayed or absent for up to 4 d after infection. These differences correlate with the presence of CD1b, but the absence of MHCII at the Mtb phagosome, and are observed despite the successful induction of DC maturation. We suggest that microbial pathogens, such as Mtb, can uncouple the strict sequential relationship between MHCII antigen loading and DC maturation by delaying the formation of MHCII-peptide complexes while still rapidly inducing MHCII to traffic to the plasma membrane. Through the precocious induction of DC maturation, invading pathogens create a window of opportunity for growth and dissemination, not by blocking maturation or MHCII trafficking, but by disordering the sequence of antigen loading and MHCII trafficking to the plasma membrane. In contrast, CD1b trafficking is independent of MHCII and persists as a means of initiating adaptive immunity in situations where MHCII presentation is rendered dysfunctional.
infection of DCs, CD1b-restricted antigen presentation by DCs infected with Mtb was analyzed. Immature human monocytederived DCs were infected with Mtb-expressing GFP, and at each time point after infection, DCs were fixed with glutaraldehyde and tested for their ability to stimulate the mycolic acid-specific, CD1b-restricted T cell line DN1. T cell recognition of CD1b-mycolic acid complexes on the DC cell surface occurred 20 h after infection and increased in magnitude over time as indicated by both IL-2 release and IFN-␥ secretion by activated T cells ( Fig. 1 A and B) . In the latter case, the T cell response to infected DCs is Ϸ4-fold greater than background after 20 h and plateaus between 48 and 72 h of infection (Fig. 1C ). In addition, T cell recognition of the CD1b-restricted antigen, glucose monomycolate (GMM), and the CD1c-restricted antigen, mannosyl-phosphomycoketide (MPM), was analyzed. Similar to DN1, the CD1b-restricted T cell line, LDN5, and the CD1c-restricted T cell line, CD8-1, both recognized distinct lipid antigens presented by DCs infected with Mtb 20-24 h after infection but not at 4 h after infection ( Fig. 1D and supporting information (SI) Fig. S1 ). Thus, after Mtb infection, various CD1-restricted lipid antigens are efficiently loaded onto CD1b and CD1c molecules and presented to T cells.
To compare the kinetics of MHCII antigen presentation to lipid antigen presentation, an MHCII-restricted T cell line (3F) specific for the Ag85 complex, a major secreted antigen, was derived. Surprisingly, DCs infected with Mtb failed to stimulate the 3F line ( Fig. 1 A) ; however, the same infected DCs stimulated the DN1 line ( Fig. 1 A) . To determine whether the observed nonresponsive phenotype was specific to the 3F line, a second HLA-DR-restricted T cell clone that recognizes a peptide derived from the secreted antigen CFP10 was tested in similar assays. In contrast to the rapid responses noted for the CD1-restricted T cells during the first 48 h of infection, D3 recognition of HLA-DR-antigen complexes on the cell surface was minimal (ratio of IFN-␥ secretion by D3 in response to infected DCs was Ͻ2-fold greater than background). After 48 h, a sharp increase in HLA-DR presentation to D3 became evident ( Fig. 1 E and F) . A similar response curve was observed when T cell recognition was measured by IL-2 release (data not shown). Therefore, during Mtb infection the presentation of several peptide antigens by HLA-DR is delayed relative to lipid antigen presentation by CD1.
Human DCs Undergo Maturation and Maintain CD1 Surface Expression
After Mtb Infection. Next, we examined the effect of Mtb infection on DC maturation and CD1 surface expression by flow cytometry as a possible explanation for the perceived delay in MHCII presentation. Uninfected control cells exhibited the expected immature DC phenotype indicated by the lack of cell surface expression of CD83 and low to moderate surface levels of HLA-DR, CD80, and CD86 ( Fig. 2A) . However, after infection of Mtb, DCs rapidly mature as indicated by the up-regulation of HLA-DR, CD80, CD86, and CD83 as early as 20 h after infection. DC maturation coincided with the redistribution of HLA-DR from the endocytic system to the plasma membrane, which is evident by confocal microscopy staining of infected DCs ( Fig. S2 ) and confirmed in subsequent experiments by electron microscopy ( Fig. 3C) . In contrast to HLA-DR, the localization of CD1b is unchanged and remains localized to the endocytic system in infected DCs (Fig. S2 ) as well as on the cell surface (Fig. 2B) . Immature DCs uniformly express high levels of CD1b and CD1c and exhibit a bimodal distribution of CD1a expression. Infection with Mtb for 48 h did not change the surface levels of CD1b and CD1c but slightly increased the percentage of CD1a lo cells (Fig.  2B ). To extend these observations, the expression ratios of CD1a, -b, and -c and HLA-DR surface levels on Mtb infected and uninfected DCs isolated from multiple donors were determined. This analysis revealed that in the majority of donors, CD1 expression was unchanged by Mtb infection, whereas HLA-DR expression was consistently increased (Fig. S2) . Collectively, these results demonstrate that DCs infected with Mtb mature phenotypically, resulting in increased surface expression of MHCII and costimulatory molecules, but show little change in the constitutive expression pattern of CD1 molecules.
CD1b and MHCII Differentially Localize to Mtb Phagosomes. In uninfected cells, CD1b is present in the same compartment as Lamp1, CD63, and HLA-DR in MIICs (9) . Here, we examined the localization of CD1b and MHCII in lysosomes and phagosomes containing Mtb. Early (4 h) after infection, both CD1b and HLA-DR were present on the phagosomal membrane; however, they did not fully colocalize with one another (Fig. 3A) . Interestingly, at later time points (20 h and 48 h), CD1b and HLA-DR differentially localized to the phagosome: CD1b abundantly localized to the phagosome membrane, whereas HLA-DR staining on the phagosomal membrane was less pronounced and in many cases not detected (Fig. 3A) . LAMP1 and CD63 (Fig. S3 ) exhibited a similar localization to CD1b at both 4 h and 20 h after infection. The striking localization of CD1b, LAMP1, and CD63 at all time points was detected as a ''ring'' that marked the phagosomal membrane. Importantly, the rapid and sustained colocalization correlated with the early presentation of CD1b antigens to T cells.
To confirm the localization of CD1b on phagosomal membranes, immunogold-labeled transmission electron microscopy was carried out. CD1b discretely localized to the membrane of the Mtb phagosome within just a few hours after phagocytosis and was stably present for up to 48 h after infection ( Fig. 3 B and D and Fig. S4 ). Delivery of CD1b to the phagosome by phagolysosome fusion was confirmed by detecting an accumulation of multivesicular lysosomes in the immediate area surrounding the phagosome (Fig. 3B ) and by observing LAMP1ϩ lysosomes directly fusing with the phagosome (Fig. S5) . Similar to CD1b, MHCII was present on the phagosomal membrane soon after phagocytosis (Fig. 3C) . However, at later time points after infection, MHCII was redistributed to the plasma membrane ( Fig. 3C and Fig. S4) , consistent with the occurrence of DC maturation. This change in MHCII localization coincided with a 9.4-fold reduction in the density of MHCII on the Mtb phagosome over the 48-h infection period (Fig. 3D) . In contrast, the density of CD1b on Mtb phagosomes remained stable for the first 20 h and then slightly increased between 20 h and 48 h (Fig. 3D) , reflecting a more stable steady-state localization to bacterial phagosomes than that observed for MHCII during DC maturation.
We next used inert polystyrene beads to induce phagosomes in DC and found that unlike Mtb phagosomes, they were positive for CD1b and MHCII at both 4 h and 20 h after phagocytosis (Fig. 4 and Fig. S6, arrowheads) , suggesting that bacterial components must be present to induce the differential localization of CD1b and MHCII at phagosomes. To test this, we examined the localization of CD1b and MHCII to phagosomes formed with polystyrene beads coated with the TLR4 agonist LPS. Similar to cells infected with Mtb, LPS-bead phagosomes stained positively for CD1b and MHCII at 4 h after uptake; however, although they remained CD1b-positive, they became MHCII-negative after 20 h (Fig. 4 and Fig. S6, arrowheads) . This correlated precisely with the relocalization of MHCII to the plasma membrane ( Fig. 4 ; note green labeling of cell surface at 20 h). Similar localizations were observed when phagosomes were formed with zymosan, which contains TLR2/6 agonists (Fig. S6) . Thus, as TLR ligands expressed by pathogens regulate DC maturation, they differentially stimulate MHCII trafficking from phagosome to the plasma membrane, whereas CD1b does not undergo a similar maturation-induced redistribution.
Bacterial Gene Expression Is Repressed Early After Phagocytosis.
Given the transient intersection of MHCII with bacterial phagosomes, the formation of peptide-MHCII complexes would be governed by the availability of processed peptide antigens during this time. As such, the gene expression patterns of the genes encoding the Ag85 complex ( fbpA and fbpB) and ESAT6, which is cotranscribed with CFP10 (19) , were determined by quantitative PCR. The expression level for each gene in infected DC cultures over time was determined relative to that observed in bacteria grown in T cell media without DC. Whereas fbpA expression was moderately reduced 4 h after infection (1.5-fold), ESAT6 and fbpB expression were sharply reduced, 9.5-and 16.9-fold, respectively (Fig. 5) . After this initial drop, the expression of each gene steadily increased over the remaining 3 d; remarkably, the induction of ESAT6 expression paralleled the occurrence of MHCII-restricted T cell recognition (Fig. 1) . Thus, the early and substantial repression of Mtb gene expression restricts the potential pool of peptide antigens, which likely contributes to the delayed or absent MHCII antigen presentation.
CD1b and Bacterial Lipids Colocalize Rapidly After Infection.
The ability of CD1b to quickly present lipid antigens after Mtb infection and the localization of CD1b to Mtb phagosomes led us to examine the intracellular localization of Mtb lipids by confocal microscopy. Mtb-infected DCs were stained with monoclonal antibody against CD1b and antisera against lipoarabinomannan (LAM), a Mtb cell wall glycolipid involved in the manipulation of Mtb phagosome maturation in macrophages and also a CD1b-presented antigen (13, 20) . In infected DCs, LAM was strictly detected in the Mtb phagosome, where it was found on the bacterial cell surface (Fig.  6A) . A similar localization was observed in cells infected with heat-killed bacteria (Fig. S7) , suggesting that innate properties of the DC phagosome restrict lipid antigen traffic. Next, we examined the intracellular localization of CD1b in the same infected DCs. As observed in Fig. 3 , CD1b localized to the phagosome of both live and dead bacteria in a pattern indicative of localization to the phagosomal membrane ( Fig. 6A; see Fig. S7 ).
To further support the hypothesis that CD1b antigens may be loaded in phagolysosomes, the localization of the CD1 accessory protein, Saposin C, in infected DCs was examined. Saposins are endosomal lipid transfer proteins and Saposin C has been implicated in the loading and transfer of lipids into CD1b (21) . Like other lysosomal proteins, Saposin C intensely stained the Mtb phagosomes at both 4 h and 20 h after infection where it colocalized with CD1b ( Fig. 6B and see Fig. S7 ). Additionally, 25-30% of Mtb phagosomes stained positively with Lysotracker-Red at 4 h, 20 h, and 48 h after infection. Thus, the localization of CD1b, CD1b-presented antigens, and antigen loading accessory molecules to the Mtb phagosome during the initial hours after phagocytosis correlates with the early presentation of lipid antigens to T cells, implicating the phagolysosome as the probable antigen-loading compartment for CD1b.
Discussion
The question of how MHCII and CD1b antigen-presenting molecules may function differently led us to compare lipid and peptide antigen presentation during a microbial infection. We find that after Mtb infection of DCs, lipid antigen presentation by CD1b occurs earlier and is uncompromised compared with peptide antigen presentation by MHCII. CD1b-lipid antigen complexes were detected on the cell surface within the first 24 h after infection, and the magnitude of the CD1b-restricted T cell response increased with time. In contrast, the appearance of MHCII-antigen complexes that could be recognized by T cells was delayed, and in some cases, absent for up to 72 h after infection. This delay was observed despite the rapid maturation of infected DCs, and in fact, likely results from the discoordination of antigen availability and DC maturation, a notion that is supported by the delayed induction of Mtb protein gene expression after infection. The difference between CD1b and MHCII presentation also correlated with the intersection of CD1b and MHCII with Mtb after phagocytosis. Confocal and immunogold electron microscopy experiments showed that both CD1b and MHCII localize to the phagosomal membrane within hours after phagocytosis. However, after 20 h of infection, CD1b still strikingly has access to the phagosome but not MHCII. Instead, MHCII had moved predominantly to the plasma membrane consistent with the rapid maturation of infected DCs. These differences were recapitulated in TLR ligand coatedpolystyrene bead phagosomes. Thus, TLR ligands induce MHCII trafficking to the plasma membrane, but the same pattern does not occur for CD1b. We suggest that by the time peptide antigens secreted by Mtb become available for processing and loading in the phagolysosome, the majority of MHCII molecules already may have moved to the cell surface therefore limiting the pool of intracellular MHCII molecules available for peptide loading. The trafficking of MHCII molecules and the formation of MHCII-peptide complexes are tightly coupled to the maturation state of DCs. In immature DCs, MHCII is localized to the MIIC where it is found on internal membranes associated with invariant chain (Ii). This localization is essential for peptide loading onto MHCII mediated by HLA-DM, which does not occur efficiently on the limiting membrane of bacterial phagosomes (22) . DC maturation induces the formation of MHCII-peptide complexes (4-7) and the induction of lysosomal proteolysis (23) , enabling the sequential degradation of invariant chain and the generation of peptides to be loaded on MHCII. Moreover, Ii proteolysis and the formation of MHCII-peptide complexes in microbial phagosomes is regulated in a TLR-dependent, phagosome-specific manner leading to MHCII antigen presentation to T cells (1) .
Our data suggest a model in which the tight coupling of MHCII antigen processing and loading with DC maturation may provide an opportunity for intracellular microbial pathogens to delay the initiation of MHCII-restricted T cell responses. This may occur through the rapid induction of MHCII traffic from intracellular sites to the plasma membrane (by an abundance of TLR ligands), before the synthesis of antigens in microbial phagosomes. This model is supported by the finding that expression of several bacterial antigens is significantly repressed during the initial interaction between Mtb and DCs. In addition to the regulated traffic of MHCII molecules and the formation of MHCII-peptide complexes, several features of DCs and the localization of MHCII in the bacterial phagosome may account for the delay in MHCII presentation. Particularly significant is the relatively slow rate of lysosomal proteolysis exhibited by DCs compared to macrophages (24) . Although this delay enables DCs to sequester antigens for prolonged presentation to T cells, the uncoupling of MHCII trafficking from the generation of antigenic peptides could enable pathogens to shorten the window during which antigens can be processed and loaded onto MHCII.
The regulation of CD1b trafficking during DC maturation does not follow a program analogous to that of MHCII. Instead, CD1b recycles from the plasma membrane through the endocytic system in both immature and mature DCs (11, 12) . The dichotomy of CD1b from MHCII in this regard permits CD1b to readily and continuously sample and present lipid antigens to T cells regardless of the DC maturation state. To this end, the rapid and intense colocalization of CD1b on the membrane of Mtb phagosomes with CD1b accessory molecules such as Saposin C is noteworthy. Furthermore, a significant percentage of the Mtb phagosomes in DCs are acidified, which is a crucial parameter for the loading of antigens with long acyl chains into the CD1b antigen binding groove (10, 25) . Collectively, the rapid intersection of CD1b on acidified phagosomes with CD1b accessory molecules suggests that CD1-antigen complexes form at this site. Interestingly, the localization of CD1b to the Mtb phagosome is a general phenomenon for phagosomes because it does not require live Mtb or bacterial products. Rather, it constitutes a default pathway. This is supported by the similar localization of CD1b to inert polystyrene bead phagosomes and excludes the likelihood that specific receptors direct cargo to CD1bϩ compartments. Additionally, TLR ligands in the phagosome have differential effects on CD1b and MHCII traffic, allowing the induction of precocious DC maturation by bacterial pathogens and resultant evasion of MHCII presentation. The rapid T cell response to lipid antigens suggests that they are available in bacterial cell walls early in infection. Ultimately, strong MHCII peptide presentation occurs; however, this appears to require longer periods of intracellular infection in DC and/or acquisition of antigens by immature bystander DCs. These findings underscore that not only do CD1 molecules provide T cell-mediated immunity to a distinct chemical universe of microbial antigens, but they also provide a fundamentally separate pathway of intracellular trafficking that expands the opportunity for cell-mediated immunity during microbial infection.
Materials and Methods
Monocyte-Derived DCs and T Cell Clones. Monocyte-derived DCs were derived as previously described (14) . T cell lines were maintained in RPMI medium 1640 supplemented with 2 nM IL-2 and have been previously described: CD1b-restricted T cell lines specific for mycolic acid (DN1) (26) and glucose monomycolate (GMM) (LDN5) (27) , and the CD1c-restricted mannosyl-phosphomycoketide (MPM)-specific T cell line CD8 -1 (28) . To derive the antigen 85 (Ag85)-specific T cell line 3F, peripheral blood mononuclear cells (PBMC) were stimulated with 20 g/ml purified Ag85 (Colorado State University, Fort Collins, CO) in RPMI medium 1640 containing 5% human male AB serum (Omega Scientific), 10 mM Hepes buffer, 2 mM L-glutamine, and 100 units/100 g/ml penicillin/streptomycin (Cambrex). After 5 d, 20 units/ml recombinant human IL-2 (Teceleukin; National Cancer Institute) was added to wells. Cryopreserved autologous PBMC were thawed on day 14, irradiated (5,000 rads), and stimulated with antigen for 2 h, washed, added to cell lines, and after 2 d, T cells were expanded with IL-2. After two rounds of Ag85 stimulation, Ag85-specific lines were determined by a split well assay by measuring [H 3 ]thymidine incorporation and IFN-␥ cytokine secretion by ELISA (BD Biosciences). The CFP10-specific T cell clone was derived as previously described (29) .
Bacterial Strains and In Vitro Infections. The Mtb strain used in these studies was H37Rv expressing green-fluorescent protein (GFP) and infections were performed as described (14) . Polystyrene beads (3 M; Polysciences, Inc.) were coated with LPS (100 g/ml; Salmonella typhimurium) for 1 h at 37°C or incubated for the same time period in PBS. Beads were washed extensively in PBS before use. Alexa488-conjugated Zymosan (Molecular Probes) was diluted in RPMI medium 1640 and administered to cells at an multiplicity of infection of 1.
T Cell Assays. At each time point, DCs were washed with PBS, fixed with 0.04% glutaraldehyde, and cultured with T cells at a 1:1 ratio. Supernatants were assayed for IFN-␥ after 24 h by sandwich ELISA (Pierce Endogen). T cell proliferation was assessed after 3 d of DC-T cell culture by measuring [ 3 H]thymidine uptake for the final 24 h of culture, and IL-2 release was assayed on HT-2 cells as described (10) .
Flow Cytometry. Flow cytometry was performed by using mouse monoclonal antibodies as previously described (12): P3 (IgG1 control), IgG2a control (Sigma), 10H3.9 (anti-CD1a), BCD1b3 (anti-CD1b), F10/21A3 (anti-CD1c), IVA12 (anti-HLADR), and anti-CD80, -CD83, and -CD86 (BD Biosciences). Primary antibodies were detected by using phycoerythrin-conjugated goat anti-mouse F(abЈ) 2 fragments (Biosource). Data were acquired on a FACSort flow cytometer (Becton Dickinson) and analyzed by using FlowJo (version 6.3.2).
RNA Isolation and Quantitative PCR (qPCR).
Infected DCs or Mtb grown in complete T cell media were harvested, suspended in TRI reagent (Sigma), and subjected to bead beating with 0.1-mm zirconium/silica beads to lyse Mtb. Lysates were extracted with chloroform, and RNA was precipitated with isopropanol. Reverse transcription reactions were performed with 1 g of total RNA by using the Quanitect Reverse Transcription kit with genomic DNA wipeout (Qiagen). An aliquot of each reverse transcription reaction was added to PCRs containing Brilliant SYBR green master mix (Stratagene) and gene specific primers. The sequences of the ESAT6, fbpA, and fbpB oligos have been published (30, 31) , and for 16S RNA primer sequences were 5Ј-gcgatacgggcagactagag-3Ј and 5Јaaggaag-gaaacccacacct-3Ј. Data were collected and analyzed by using the Mx3000P qPCR system (Stratagene). ESAT6, fbpA, and fbpB expression from each infected culture was normalized to 16S RNA expression in the same sample. Changes in ESAT6, fbpA, and fbpB expression over time were expressed relative to the expression levels observed in bacterial cultures grown in complete T cell media for the same period.
Confocal Microscopy. DCs were plated on fibronectin (20 g/ml)-coated glass coverslips and fixed with 2% formaldehyde. When used, Lysotracker Red D-99 (200 nM; Molecular Probes) was added for the final 30 minutes of incubation. Cells were permeabilized with 0.2% Saponin and labeled with the following antibodies: H4A3 (LAMP1; BD Biosciences), H5C6 (CD63; BD Biosciences), BCD1b3, IVA12, rabbit anti-LAM antisera (Daniel Clemens, University of California, Los Angeles), and rabbit anti-Saponin C antisera (Greg Grabowski, Cincinnati Children's Hospital Medical Center, Cincinnati, OH). Primary antibodies were detected with Alexa546-conjugated (Molecular Probes) or Cy5-conjugated (Jackson Immunochemicals) antibodies. For CD1b and MHCII colocalization studies, fixed cells were stained with BCD1b3 and detected with goat anti-mouse Alexa546-conjugated antibodies. Labeled cells were blocked with unconjugated mouse IgG1 antibody and subsequently labeled with either Alexa647-conjugated P3 (control) or Alexa647-conjugated IVA12. Confocal microscopy images were acquired on a Nikon C-1 confocal microscope by using EZ C1 software. Images were processed and analyzed in Adobe Photoshop CS version 8.0 by applying the unsharp mask filter to each image.
Electron Microscopy. Cells were fixed and processed for cryosectioning as previously described (11) and stained with the following antibodies: 10H3.9 (CD1a), BCD1b3 (CD1b), SG520 (HLA-DR, -DP, and -DQ), H4A3 (Lamp1), and H68.4 (Transferrin receptor; Zymed).
